SkinBioTherapeutics appoints interim CEO as investigation continues
SkinBioTherapeutics PLC on Monday announced Rachel Parsonage has been appointed as interim chief executive officer effective immediately as the life science firm tries to carve...
Mon, 02/03/2026 - 16:27